|
|
Memantine (Axura)
Substance developed by the Merz research organization used to treat dementia and Alzheimer's Disease.
memantine.com - Mode of Action
Mode of Action. Memantine as an NMDA receptor antagonist can prevent the pathological ... Mode of action of memantine (Interactive animation) ...
Memantine - Wikipedia, the free encyclopedia
Memantine agonist action at dopamine D2High receptors" ... The molecular basis of memantine action in Alzheimer's disease and other ...
Memantine: Information from Answers.com
Memantine Memantine is a new drug for treating Alzheimer's disease, mental ... The molecular basis of memantine action in Alzheimer's disease and other ...
FDA Approves Alzheimer's Drug
The entry page to Global Action on Aging's Web site. ... and blocking its action may explain Memantine's benefits, Ferris said. ...
Namenda (Memantine), Alzheimer's medication
Namenda (Memantine)is a medication used in the treatment ... Mechanism of Action and ... Memantine is postulated to exert its therapeutic effect through ...
Memantine - Pubdrug
2 Mechanism of Action. 3 Time Required for Therapeutic ... causing a similar action to that of magnesium, though memantine stays in the channel longer. ...
Mechanism of memantine block of NMDA-activated channels in rat retinal ...
... approached zero, a small residual action of memantine may be explained by the ... appeared at least 10-20-fold faster than the kinetics of memantine action. ...
Memantine Upregulates BDNF and Prevents Dopamine Deficits in SIV ...
This novel pharmacological action of memantine may also be relevant for other ... The molecular basis of memantine action in Alzheimer's disease and other ...
Memantine
Hypersensitivity to memantine or any component of the formulation ... Store at controlled room temperature of 15°C to 30°C (59°F to 86°F). Mechanism of Action: ...
|
|
|
|
Action of memantine |
Memantine and Intensive Speech-Language Therapy in Aphasia - Full Text View - ClinicalTrials.gov
Home
Search
Study Topics
Glossary
Aphasia, the loss or impairment of language caused by brain damage, is one of the most devastating cognitive impairments of stroke. Aphasia can be treated with combination of speech-language therapy and drugs. Conventional speech-language therapy in chronic aphasic subjects is of little help and several drugs have been studied with limited success. Therefore other therapeutic strategies are warranted.
CIAT is an intensive form of language-action therapy for aphasia performed in a small group setting. In a therapeutic game context, participants had to request objects or cards from each other and understand requests made by others. Feedback of communicative success was regularly given, along with guidance, help and reinforcement. Gesturing replacing verbal language was discouraged although gestures accompanying speech were allowed.
|
Rating: 3.5 èç 5 (ãîëîñîâ: 151) |
|
10 october 2008
Ãåíàäèé Ïå÷íîé
|
|
|
|
|
memantine online
memantine 5
merz memantine
ebixa memantine
|
|
|
|
|
|
|
|
|
|
|